A pioneering contract manufacturer in Brunei Darussalam, Simpor Pharma Sdn Bhd aims to become the hub for exporting Halal pharmaceutical products and health supplements in the global market.
Simpor Pharma offers comprehensive contract manufacturing services for branded nutraceutical and pharmaceutical companies to meet the demands of this fast-growing market. This is also opening great investment opportunities for the Sultanate while providing Halal pharmaceutical products to 1.9 billion Muslims across the world.
Certified by strict internationally recognised standards, Simpor is a global integrated contract manufacturer to provide the nutraceutical and pharmaceutical industry with a wide array of innovative and tailor-made solutions.
Simpor Pharma Sdn Bhd in Brunei complies with the worldwide current GMP standard for pharmaceutical products and health supplements, including softgels, hard shell capsules, tablets, powder and oral liquid.
Sengenics is a genomics and proteomics-based research and diagnostics company that opened its new DNA sequencing and microarray facility at Universiti Brunei Darussalam (UBD) in 2015. The partnership between UBD and Sengenics grew from a research collaboration agreement, which began in July 2014.
The Brunei-based facility focusses on two core activities. Firstly, the company offers commercial services leveraging its patented autoantibody profiling platform and the clinical genomics diagnosis pipeline. Second, in collaboration with UBD and supported by the Brunei Economic Development Board (BEDB) through the Brunei Research Incentive Scheme (BRISc), Sengenics has embarked upon two novel Halal meat and food related research and commercialisation projects.
In April 2017, the new Sengenics Immunome Production Facility was opened in UBD. The new facility offers protein cloning and expression services using the patented BCCP (biotin carboxyl carrier protein) folding marker technology. This supports the commercially available flagship technology that is offered by Sengenics, the Immunome Protein Array Platform, which is used for a variety of pharmaceutical screening and drug discovery applications.
Copyright 2019 Borneo Bulletin Yearbook 2019 All rights reserved.